Sobol, P. T., Boudreau, J. E., Stephenson, K., Wan, Y., Lichty, B. D., & Mossman, K. L. (2011). Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy. Nature Publishing Group.
Chicago-stil citatSobol, Paul T., Jeanette E. Boudreau, Kyle Stephenson, Yonghong Wan, Brian D. Lichty, och Karen L. Mossman. Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy. Nature Publishing Group, 2011.
MLA-referensSobol, Paul T., et al. Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy. Nature Publishing Group, 2011.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.